Hypofractionated stereotactic radiation therapy in recurrent high-grade glioma: A new challenge

Research output: Contribution to journalArticle

Abstract

Purpose The aim of this study was to evaluate outcomes of hypofractionated stereotactic radiation therapy (HSRT) in patients re-treated for recurrent high-grade glioma. Materials and Methods From January 2006 to September 2013, 25 patients were treated. Six patients underwent radiation therapy alone, while 19 underwent combined treatment with surgery and/or chemotherapy. Only patients with Karnofsky Performance Status (KPS) > 70 and time from previous radiotherapy greater than 6 months were re-irradiated. The mean recurrent tumor volume was 35 cm3 (range, 2.46 to 116.7 cm3), and most of the patients (84%) were treated with a total dose of 25 Gy in five fractions (range, 20 to 50 Gy in 5-10 fractions). Results The median follow-up was 18 months (range, 4 to 36 months). The progression-free survival (PFS) at 1 and 2 years was 72% and 34% and the overall survival (OS) 76% and 50%, respectively. No severe toxicity was recorded. In univariate and multivariate analysis extent of resection at diagnosis significantly influenced PFS and OS (p <0.01). Patients with smaller recurrent tumor volume treated had better local control and survival. Indeed, the 2-year PFS was 40% (<50 cm3) versus 11% (p=0.1) and the 2-year OS 56% versus 33% (> 50 cm3), respectively (p=0.26). Conclusion In our experience, HSRT could be a safe and feasible therapeutic option for recurrent high grade glioma even in patients with larger tumors. We believe that a multidisciplinary evaluation is mandatory to assure the best treatment for selected patients. Local treatment should also be considered as part of an integrated approach.

Original languageEnglish
Pages (from-to)37-44
Number of pages8
JournalCancer Research and Treatment
Volume48
Issue number1
DOIs
Publication statusPublished - 2016

Keywords

  • Glioma
  • Radiosurgery
  • Retreatment

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Hypofractionated stereotactic radiation therapy in recurrent high-grade glioma: A new challenge'. Together they form a unique fingerprint.

  • Cite this